CellenGene Achieves US Patent Approval for Breakthrough CAR-T Therapy Targeting Solid Tumors
CellenGene Co., Ltd. (CEO Ahn Jae-hyung), a Korean drug development company, received approval for the US patent on "Receptor and ...
KoreaTechDesk | Korean Startup and Technology News
CellenGene Co., Ltd. (CEO Ahn Jae-hyung), a Korean drug development company, received approval for the US patent on "Receptor and ...
Korean Medical AI startup Lunit has signed a strategic partnership with Guardant Health, a US bio-health care company, with an ...